Ivan Zlatev
11Patents
3h-index
22Co-inventors
56Inventor score
Filing activity: Dec 22, 2009 → Jan 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8927513B2 | 5′ phosphate mimics | Chemistry; Metallurgy | 45 | Active |
| US9156873B2 | Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom | Chemistry; Metallurgy | 17 | Active |
| US9725479B2 | 5′-end derivatives | Chemistry; Metallurgy | 12 | Active |
| US10119136B2 | RNAi agents modified at the 4′-C position | Chemistry; Metallurgy | 3 | Active |
| US10131908B2 | 5′ phosphate mimics | Chemistry; Metallurgy | 3 | Active |
| US12241064B2 | REVERSIR™ compounds | Chemistry; Metallurgy | 0 | Active |
| US12221607B2 | Multi-targeted single entity conjugates | Chemistry; Metallurgy | 0 | Active |
| US11053495B2 | Multi-targeted single entity conjugates | Chemistry; Metallurgy | 0 | Active |
| US11286482B2 | Endosomal cleavable linkers | Chemistry; Metallurgy | 0 | Active |
| US9035041B2 | Process for triphosphate oligonucleotide synthesis | Chemistry; Metallurgy | 0 | Active |
| US12018260B2 | Tunable Reversir™ compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.